Inhibition of tristetraproline for protection of the heart from cardiac injuries
CA 2470148 C · Owner: Hoheisel, Joerg Dietrich · Inventors: Braendle, Marian; Zubakov, Dimitri; Hoheisel, Joerg Dietrich
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to compounds suitable for the treatment of conditions which may be improved, at least in part by increasing TNF .alpha. , production. The invention further relates to assays for the identification of an individual at increased risk for or suffering from such conditions and to methods of screening compounds for their ability to enhance TNF .alpha. biosysthesis.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 30, 2002 and granted March 17, 2015. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 30, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 30, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.